Core Viewpoint - Arcadium reported quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.05 per share, representing an earnings surprise of -80% compared to $0.44 per share a year ago [1] - The company posted revenues of $203.1 million for the quarter ended September 2024, missing the Zacks Consensus Estimate by 22.82%, and down from $211.4 million year-over-year [2] Financial Performance - Over the last four quarters, Arcadium has surpassed consensus EPS estimates only once [2] - The company has also topped consensus revenue estimates just once in the last four quarters [2] - Arcadium shares have declined approximately 69.7% since the beginning of the year, contrasting with the S&P 500's gain of 24.3% [3] Future Outlook - The company's earnings outlook will be crucial for investors, particularly in light of management's commentary on the earnings call [3][4] - Current consensus EPS estimate for the upcoming quarter is $0.05 on revenues of $282.47 million, and $0.21 on revenues of $1.06 billion for the current fiscal year [7] - The estimate revisions trend for Arcadium is mixed, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Chemical - Specialty industry, to which Arcadium belongs, is currently ranked in the bottom 46% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Arcadium's stock performance [5]
Arcadium (ALTM) Q3 Earnings and Revenues Miss Estimates